Takeda Strengthens Berlin Site as Future German Headquarters

Takeda, a leading global pharmaceutical company, has announced its decision to move the headquarters of Takeda GmbH – its German subsidiary – from Constance to Berlin by the end of 2028. Berlin already serves as a central hub for key commercial operations in Germany. With this move, Takeda is reinforcing its presence in the capital and will concentrate its activities on three strategic locations: Berlin, Oranienburg, and Singen. The state-of-the-art manufacturing sites in Singen and Oranienburg will remain integral pillars of the organisation, underscoring Germany’s importance as a key industrial base for Takeda.

“Relocating our corporate headquarters to Berlin is a clear commitment to Germany, Takeda’s fourth-largest market,” said Dr Ingeborg R. Borgheim, Managing Director of Takeda in Germany. “We are strengthening our footprint in Berlin alongside our two global manufacturing sites in Singen (Baden-Württemberg) and Oranienburg (Brandenburg).”

The relocation is expected to be completed by the end of 2028. The Constance site, which historically served as the headquarters of Takeda GmbH and Takeda Germany, will be closed by year-end 2028. Approximately 60 employees based in Constance have been informed of the plans.

“We recognise that this represents a significant change for our colleagues in Constance,” said Michael Hartmann, Managing Director of Human Resources and Labour Relations at Takeda Germany. “With today’s announcement, we are ensuring early and transparent communication. We are currently in discussions with the works council.”

With 2,300 employees in Germany, two global manufacturing sites, and the future national headquarters in Berlin, Takeda is sending a strong signal of its long-term commitment to Germany.